Plain-English translation of NCT06349642 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers at Mayo Clinic are studying a new diagnostic platform called Elephas that aims to predict whether immunotherapy treatments will work for your specific cancer. By collecting small tissue samples from patients with various cancer types, the team hopes to train and validate this tool so it can better help doctors choose the right immunotherapy for each patient's tumor.
Current immunotherapy treatments work very well for some patients but not others, and doctors don't have a reliable way to predict in advance who will benefit. This trial exists to develop a tool that could help doctors predict treatment response and ultimately give patients a better chance of choosing a therapy that will actually work for them.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will have a tissue biopsy (a small sample of your tumor) collected as part of your standard cancer care. You may also choose to give a blood sample and allow the researchers to review your medical records. You will continue to receive your regular immunotherapy treatment as planned by your doctor, and the study team will track how well the treatment works for you using standard imaging and tumor assessments. There is no specific study duration listed, but your involvement will likely continue as long as you are receiving treatment.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
United States